A detailed history of Hallmark Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hallmark Capital Management Inc holds 70,755 shares of BMY stock, worth $4.17 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
70,755
Previous 70,165 0.84%
Holding current value
$4.17 Million
Previous $2.91 Million 25.68%
% of portfolio
0.28%
Previous 0.24%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$39.66 - $51.75 $23,399 - $30,532
590 Added 0.84%
70,755 $3.66 Million
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $87,584 - $115,306
-2,176 Reduced 3.01%
70,165 $2.91 Million
Q1 2024

May 03, 2024

BUY
$47.98 - $54.4 $364,408 - $413,168
7,595 Added 11.73%
72,341 $3.92 Million
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $280,165 - $334,315
5,779 Added 9.8%
64,746 $3.32 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $45,617 - $51,007
-788 Reduced 1.32%
58,967 $3.42 Million
Q2 2023

Jul 28, 2023

SELL
$63.71 - $70.74 $90,149 - $100,097
-1,415 Reduced 2.31%
59,755 $3.82 Million
Q1 2023

May 03, 2023

SELL
$65.71 - $74.53 $18,004 - $20,421
-274 Reduced 0.45%
61,170 $4.24 Million
Q4 2022

Feb 01, 2023

SELL
$68.48 - $81.09 $46,087 - $54,573
-673 Reduced 1.08%
61,444 $4.42 Million
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $164 - $97,509
-1,269 Reduced 2.0%
62,117 $4.42 Million
Q2 2022

Nov 16, 2022

BUY
$72.62 - $79.98 $92,154 - $101,494
1,269 Added 2.04%
63,386 $4.88 Million
Q2 2022

Aug 01, 2022

BUY
$72.62 - $79.98 $96,076 - $105,813
1,323 Added 2.13%
63,386 $4.88 Million
Q1 2022

May 02, 2022

BUY
$61.48 - $73.72 $109,065 - $130,779
1,774 Added 2.94%
62,063 $4.53 Million
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $170,543 - $198,813
3,180 Added 5.57%
60,289 $3.76 Million
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $56,684 - $66,398
958 Added 1.71%
57,109 $3.38 Million
Q2 2021

Aug 03, 2021

BUY
$61.91 - $67.42 $273,208 - $297,524
4,413 Added 8.53%
56,151 $3.75 Million
Q1 2021

Apr 22, 2021

BUY
$59.34 - $66.74 $478,221 - $537,857
8,059 Added 18.45%
51,738 $3.27 Million
Q4 2020

Feb 02, 2021

SELL
$57.74 - $65.43 $2,482 - $2,813
-43 Reduced 0.1%
43,679 $2.71 Million
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $214,501 - $237,695
-3,735 Reduced 7.87%
43,722 $2.64 Million
Q2 2020

Jul 28, 2020

SELL
$54.82 - $64.09 $56,574 - $66,140
-1,032 Reduced 2.13%
47,457 $2.79 Million
Q1 2020

Apr 24, 2020

BUY
$46.4 - $67.43 $2.06 Million - $3 Million
44,462 Added 1104.1%
48,489 $2.7 Million
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $198,168 - $258,493
4,027 New
4,027 $258,000
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $159,977 - $199,394
-3,166 Closed
0 $0
Q1 2018

Apr 27, 2018

BUY
$59.92 - $68.98 $189,706 - $218,390
3,166 New
3,166 $201,000
Q4 2017

Jan 24, 2018

SELL
$59.94 - $65.35 $192,167 - $209,512
-3,206 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$55.23 - $63.74 $177,067 - $204,350
3,206
3,206 $205,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hallmark Capital Management Inc Portfolio

Follow Hallmark Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hallmark Capital Management Inc with notifications on news.